Skip to main content
Equibles
UTMD logo

UTMD · Utah Medical Products Inc · Metrics

Track UTMD — free

Use UTMD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research UTMD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$73.63 +0.60 (+0.82%) At close · Nov 12
Russell 2000 member Rebalance outlook locked
Market Cap
$234.42M
Shares
3.18M
Volume · Nov 12 13.08K Avg daily vol (3M) 36.51K

UTMD metrics

110 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$73.63
Market cap
$234.42M

Price action

23 metrics
Price change (1W)
+0.8%
Price change (30D)
-2.2%
Price change (3M)
+1.2%
Price change (6M)
+14.0%
Price change (YTD)
+30.5%
Price change (1Y)
+27.7%
Trailing year
Price change (5Y)
-30.7%
52-week high
$76.66
52-week low
$53.80
Change from 52-week high
-4.7%
Change from 52-week low
+35.7%
Annualized volatility
29.0%
Annualized volatility (3M)
25.7%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
0.3
RSI (14D)
52.5
Price vs SMA 50
+0.1%
Price vs SMA 200
+6.7%
Avg volume (3M)
36,536
Relative volume
0.6
Average dollar volume
$2.66M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
3.18M

Valuation

12 metrics
P / E (TTM)
22.3
Trailing earnings · reciprocal yield 4.5%
PEG ratio
—
EV / revenue
4.0×
reciprocal yield 24.9%
EV / EBITDA
—
EV / EBIT
14.1×
reciprocal yield 7.1%
P / sales
6.4×
reciprocal yield 15.5%
P / book
1.9
reciprocal yield 52.5%
FCF yield
4.9%
TTM · current market cap
Buyback yield
0.8%
P / FCF
20.3
reciprocal yield 4.9%
P / operating cash flow
19.6
reciprocal yield 5.1%
Earnings yield
4.5%

Historical valuation

8 metrics
P / E historical average (3Y)
16.5×
reciprocal yield 6.1%
P / E historical average (5Y)
18.6×
reciprocal yield 5.4%
EV / revenue historical average (3Y)
3.0×
reciprocal yield 32.9%
EV / revenue historical average (5Y)
4.0×
reciprocal yield 24.9%
EV / EBIT historical average (3Y)
9.6×
reciprocal yield 10.5%
EV / EBIT historical average (5Y)
11.5×
reciprocal yield 8.7%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
1.7%
Trailing 12 months
Payout ratio
37.6%
Shareholder yield
2.5%
Dividend / share (TTM)
$1.24
Dividend growth YoY
+1.6%
Dividend growth streak
3
Last ex-dividend
2026-09-17

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
57.9%
Operating margin
28.4%
Trailing 12 months
Net margin
29.0%
Gross profit (TTM)
$20.91M
Operating profit (TTM)
$10.27M
Net income (TTM)
$10.49M
Trailing 12 months
Diluted EPS (TTM)
$3.28
FCF margin
31.7%
Effective tax rate
18.6%

Per share

11 metrics
Revenue per diluted share (TTM)
$11.30
Gross profit per diluted share (TTM)
$6.55
Operating profit per diluted share (TTM)
$3.21
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$3.28
Operating cash flow per diluted share (TTM)
$3.71
Free cash flow per diluted share (TTM)
$3.58
Capital expenditures per diluted share (TTM)
$0.13
R&D per diluted share (TTM)
$0.22
Stock compensation per diluted share (TTM)
$0.12
Book value per share
$37.44

Growth

11 metrics
Revenue growth YoY
-14.3%
Year over year
Net income growth YoY
-11.9%
Revenue (TTM)
$36.11M
Trailing 12 months
EPS growth YoY
-10.6%
Shares change YoY
-1.9%
Year over year · fewer shares
Revenue CAGR (3Y)
-9.7%
Revenue CAGR (5Y)
-1.8%
EPS CAGR (3Y)
-8.3%
EPS CAGR (5Y)
+3.4%
FCF CAGR (3Y)
-11.0%
FCF CAGR (5Y)
-5.8%

Quality

14 metrics
Return on equity
8.6%
Return on assets
8.4%
Debt / equity
0.0
Current ratio
48.6
EBITDA (TTM)
—
Free cash flow (TTM)
$11.45M
Quick ratio
44.3
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
24.1%
Trailing 12 months
Net cash
$87.33M
Latest balance sheet
Cash & equivalents
$87.53M
Total assets
$124.57M
Total debt
$195,000

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$11.85M
Capital expenditures (TTM)
$400,000
R&D (TTM)
$687,000
SG&A (TTM)
—
Stock compensation (TTM)
$397,000
R&D / revenue
1.9%
Stock compensation / revenue
1.1%

Ownership (13F)

9 metrics
13F filers
115
13F filer change QoQ
-4
Institutional ownership
72.8%
Conviction holders (share of 13F filers)
0.9%
Crowding (high-turnover and private-fund holders)
38.2%
Private-fund adviser ownership
37.9%
Active holders' share change QoQ
+2.1%
Holder tenure
16.2
Price vs estimated holder cost
+5.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
12.6%

Short interest

3 metrics
Short interest
4.8%
Latest settlement · 3.9 days to cover
Days to cover
3.9d
Short-squeeze score
71 / 100

Insider activity

2 metrics
Net insider buying (90D)
$66,750
Insider-sentiment score
79 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 706698 CUSIP 917488108 13F (30d) 82 filings 69 filers Visit website Investor relations